Education
About Us
Working with TipRanks
Follow Us
Co-Diagnostics Inc (CODX)
NASDAQ:CODX
Earnings Data
Report Date
Nov 06, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.18Last Year’s EPS
-0.32Same Quarter Last Year
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Negative
The earnings call highlighted significant advancements in Co-Diagnostics' Co-DX PCR platform development, supported by major grants and upcoming clinical evaluations. However, these positives were overshadowed by a sharp revenue decline and increased losses, indicating financial challenges.Company Guidance
Advancement of Co-DX PCR Platform
Co-Diagnostics has made steady advancements on its Co-DX PCR point-of-care platform, with plans to initiate clinical evaluations for all tests in the pipeline during 2025.
Grants from Major Organizations
The development of the TB and HPV tests is supported by grants from the Bill & Melinda Gates Foundation, and the 4-plex respiratory panel is supported by a grant from the National Institute of Health's RADx Tech program.
Progress on TB Test
Preliminary studies for the Co-DX PCR MTB test are completed or in process, with plans to begin clinical evaluations in India and South Africa by the end of 2025.
Upcoming Clinical Evaluations
Co-Diagnostics plans to start clinical evaluations for the COVID-19, ABCR 4-plex, TB, and HPV tests in 2025, with the COVID-19 test already beginning site visits and training.
Innovative Cloud-Based Analysis
The Co-DX PCR platform includes a cloud-based analysis feature that provides epidemiological data to health departments, a feature supported by the Bill & Melinda Gates Foundation and the National Institute of Health's RADx Tech program.
CODX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CODX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 14, 2025 | $0.26 | $0.29 | +11.54% |
May 08, 2025 | $0.36 | $0.34 | -5.56% |
Mar 27, 2025 | $0.39 | $0.32 | -17.95% |
Nov 07, 2024 | $1.18 | $1.14 | -3.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Co-Diagnostics Inc (CODX) report earnings?
Co-Diagnostics Inc (CODX) is schdueled to report earning on Nov 06, 2025, Before Open (Confirmed).
What is Co-Diagnostics Inc (CODX) earnings time?
Co-Diagnostics Inc (CODX) earnings time is at Nov 06, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CODX EPS forecast?
CODX EPS forecast for the fiscal quarter 2025 (Q3) is -0.18.